Roivant president sells 200K shares after exercise
Roivant Sciences Ltd. president and Immunovant CEO Eric Venker reported an exercise-and-sale transaction in the company’s common shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Roivant Sciences Ltd. president and Immunovant CEO Eric Venker reported an exercise-and-sale transaction in the company’s common shares. He exercised stock options to acquire 200,000 common shares at $3.85 per share and sold 200,000 common shares in open-market transactions at a weighted average price of $29.59 per share, with individual trade prices ranging from $29.33 to $29.88. Following these transactions, he directly holds 1,647,546 common shares. A related stock option award to purchase common shares is described as fully vested.
Insider Trade Summary 10b5-1
Exercise and sale activity reported; no spread calculated
Exercise and Sale
3 txns
Insider
Venker Eric
Role
President & Immunovant CEO
Sold
200,000 shs ($5.92M)
Approx. gross sale proceeds
$5.92M
Approx. exercise cost
$770K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 200,000 | $0.00 | $0.00 |
| Exercise | Common Shares | 200,000 | $3.85 | $770K |
| Sale | Common Shares | 200,000 | $29.59 | $5.92M |
Holdings After Transaction:
Stock Option (Right to Buy) — 4,644,834 contracts (Direct);
Common Shares — 1,647,546 shares (Direct)
Footnotes (2)
- F1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.33 to $29.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
- F2. Reflects an award of stock options to purchase Common Shares that is fully vested.
Key Figures
Shares sold: 200,000 shares
Weighted average sale price: $29.59 per share
Shares held after transactions: 1,647,546 shares
+5 more
8 metrics
Shares sold
200,000 shares
Common shares sold in open-market transactions on 2026-04-20
Weighted average sale price
$29.59 per share
Common share sales, price range $29.33–$29.88
Shares held after transactions
1,647,546 shares
Direct beneficial ownership of common shares after 2026-04-20
Options exercised
200,000 options
Stock options exercised into common shares at $3.85 per share
Option exercise price
$3.85 per share
Exercise price for 200,000 stock options converted to common shares
Remaining stock options
4,644,834 options
Stock options outstanding after the reported derivative transaction
Option expiration date
2032-04-19
Expiration date for the reported stock option series
Sale price range
$29.33–$29.88 per share
Price range for individual trades within the 200,000-share sale
Key Terms
weighted average price, open-market sale, stock options, fully vested, +1 more
5 terms
weighted average price financial
"The price reported in column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
stock options financial
"Reflects an award of stock options to purchase Common Shares that is fully vested."
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
fully vested financial
"Reflects an award of stock options to purchase Common Shares that is fully vested."
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Eric Venker report at Roivant Sciences (ROIV)?
Eric Venker reported exercising stock options for 200,000 Roivant common shares and selling 200,000 common shares. The filing shows a combined exercise-and-sale pattern on the same date, reflecting option exercise and subsequent open-market sales of the acquired shares.
What stock options did Eric Venker exercise in the Roivant Sciences (ROIV) filing?
He exercised stock options covering 200,000 underlying common shares at an exercise price of $3.85 per share. A footnote states this award of stock options to purchase common shares is fully vested, meaning the entire option grant was exercisable at the time of the transaction.
Does Eric Venker still hold Roivant Sciences (ROIV) stock options after this transaction?
Yes. After exercising 200,000 options, the filing shows 4,644,834 stock options remaining. These options relate to rights to buy Roivant common shares and carry an expiration date in 2032 for the specific option series referenced in the derivative transaction.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates